Hyperpersonalization of cancer care: From tumor location to molecular profile - Key insights and the role of Hospital Oncology Pharmacists. A French Society for Oncology Pharmacy paper.
For decades, cancer treatment was largely organ-based, relying on conventional modalities such as surgery. Advances in molecular biology and biotechnology have profoundly transformed this paradigm by revealing shared oncogenic mechanisms across diverse tumor types. This shift has enabled the emergence of precision onco...